Chinese Plants’ Data Management, Sanitation Problems Cited in FDA Warnings

Drug GMP Report
A A
The FDA has faulted an API maker for a host of failings at its production facility in China, including tampering with official records.

To View This Article:

Login

Subscribe To Drug GMP Report